AU2022902819A0 - Vaccine construct and uses thereof - Google Patents

Vaccine construct and uses thereof

Info

Publication number
AU2022902819A0
AU2022902819A0 AU2022902819A AU2022902819A AU2022902819A0 AU 2022902819 A0 AU2022902819 A0 AU 2022902819A0 AU 2022902819 A AU2022902819 A AU 2022902819A AU 2022902819 A AU2022902819 A AU 2022902819A AU 2022902819 A0 AU2022902819 A0 AU 2022902819A0
Authority
AU
Australia
Prior art keywords
vaccine construct
vaccine
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2022902819A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stonehaven Incubate AG
Touchlight Aquaculture Ltd
Original Assignee
Stonehaven Incubate AG
Touchlight Aquaculture Ltd
Filing date
Publication date
Application filed by Stonehaven Incubate AG, Touchlight Aquaculture Ltd filed Critical Stonehaven Incubate AG
Publication of AU2022902819A0 publication Critical patent/AU2022902819A0/en
Priority to PCT/IB2023/059738 priority Critical patent/WO2024069549A1/en
Assigned to Stonehaven Incubate AG, Touchlight Aquaculture Limited reassignment Stonehaven Incubate AG Amend patent request/document other than specification (104) Assignors: Touchlight Aquaculture Limited
Abandoned legal-status Critical Current

Links

AU2022902819A 2022-09-29 2022-09-29 Vaccine construct and uses thereof Abandoned AU2022902819A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2023/059738 WO2024069549A1 (en) 2022-09-29 2023-09-29 Vaccine construct and uses thereof

Publications (1)

Publication Number Publication Date
AU2022902819A0 true AU2022902819A0 (en) 2022-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP4112648A4 (en) Anti-sars-cov-2 infection protein and vaccine
EP3947475A4 (en) Coronavirus vaccine compositions, methods, and uses thereof
EP4034548A4 (en) Coronavirus vaccines and uses thereof
EP3946320A4 (en) Hsp90-binding conjugates and formulations thereof
EP3900741A4 (en) Samrna vaccine and preparation method therefor
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
AU2022902819A0 (en) Vaccine construct and uses thereof
AU2021902407A0 (en) Vaccine construct and uses thereof
EP3923981A4 (en) Vaccine adjuvants and formulations
AU2021901259A0 (en) Immunogenic vaccines and uses thereof
AU2021903076A0 (en) SARS-CoV2 Vaccine
AU2019902524A0 (en) Immunogenic Vaccines and uses thereof
AU2022903599A0 (en) Pharmaceutical combinations and uses thereof
AU2021902406A0 (en) Self-adjuvanting VLP and uses thereof
AU2020900439A0 (en) Tpv-2l variants and uses thereof
EP4041245A4 (en) Therapeutic formulations and uses thereof
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
AU2020902546A0 (en) Vaccination methods and compositions
AU2023901437A0 (en) Self-adjuvanting VLP and uses thereof
EP4034113A4 (en) Therapeutic formulations and uses thereof
AU2022392824A1 (en) Peptides and uses thereof
AU2021903722A0 (en) Peptides and Uses Thereof
AU2021904136A0 (en) Protein formulations and uses thereof
AU2020904544A0 (en) Peptides and uses thereof
AU2020904375A0 (en) Peptides and uses thereof